Cargando…
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells
Histone deacetylase inhibitors (HDACi) induce tumour cell cycle arrest and/or apoptosis, and some of them are currently used in cancer therapy. Recently, we described a series of powerful HDACi characterized by a 1,4-benzodiazepine (BDZ) ring hybridized with a linear alkyl chain bearing a hydroxamat...
Autores principales: | Cellai, C, Balliu, M, Laurenzana, A, Guandalini, L, Matucci, R, Miniati, D, Torre, E, Nebbioso, A, Carafa, V, Altucci, L, Romanelli, M N, Paoletti, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822689/ https://www.ncbi.nlm.nih.gov/pubmed/22004558 http://dx.doi.org/10.1111/j.1582-4934.2011.01464.x |
Ejemplares similares
-
Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells
por: Laurenzana, Anna, et al.
Publicado: (2013) -
Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010) -
HDAC1 controls CIP2A transcription in human colorectal cancer cells
por: Balliu, Manjola, et al.
Publicado: (2016) -
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
por: Balliu, Manjola, et al.
Publicado: (2015) -
Sirtuins and Disease: The Road Ahead
por: Carafa, Vincenzo, et al.
Publicado: (2012)